Cellworks
South San Francisco · Founded 2005
About Cellworks
Cellworks Group operates as a life sciences technology company. The company provides iC-PHYS, a technology platform that enables drug and biomarker discovery and research in focused therapeutic areas. The company provides disease-focused drug discovery and research solutions in the areas of oncology, such as integrated tumor cell and endothelial cells with stromal inputs; inflammation diseases, such as macrophage, neutrophil, osteoclast, and T-cell; type-2 diabetes; infectious diseases; skin pigmentation and aging; and neurodegenerative. The company was founded in 2005 and is based in Saratoga, California. It has a research and development facility in Bangalore, India.
Company Facts
- Founded: 2005
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: Less than $1M
- Total funding: $33.0M
- Last round: Series Unknown (Jun 2020)
- Website: https://cellworks.life/
- Phone: 408-406-7156
Industries & Categories
Biotechnology, Health Care, Life Science, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/cellworks-93478 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.